CDC and FDA Warn of Bacterial Poisoning Linked to Wellness Clinic IV Drips

The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have issued a warning following reports of over 30 people across four states suffering from bacterial poisoning. The illnesses are linked to intravenous (IV) drips containing glutathione administered at various wellness clinics. While glutathione is marketed for detoxification and immune support, it lacks FDA approval for such uses. Investigators found that compounding pharmacies were utilizing glutathione powders intended for oral dietary supplements rather than sterile, injectable-grade substances. This improper use of non-sterile ingredients has led to severe health complications. Health officials are now urging both clinics and consumers to exercise extreme caution regarding compounded injectable products, noting that the lack of regulatory oversight for these specific wellness treatments poses a significant risk to public safety. The investigation into the source of the contamination and the practices of these compounding pharmacies remains ongoing.